Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Vertex Pharmaceuticals Inc
XETRA:VX1
Vertex Pharmaceuticals Inc
XETRA:VX1
Price:
227.65
EUR
1.16%
Market Closed
Market Cap:
€89.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
|
Greene County Bancorp Inc
NASDAQ:GCBC
|
US |
|
P
|
Perseus Mining Ltd
LSE:0TXW
|
AU |
|
Golden Goliath Resources Ltd
XTSX:GNG
|
CA |
|
P
|
Pinetree Capital Ltd
OTC:PNPFF
|
CA |
|
Yancoal Australia Ltd
ASX:YAL
|
AU |
|
Old Mutual Ltd
OTC:ODMUF
|
ZA |
|
Serko Ltd
NZX:SKO
|
NZ |
|
Lindab International AB
STO:LIAB
|
SE |
|
H
|
H & M Hennes & Mauritz AB
OTC:HMRZF
|
SE |
|
Hammond Power Solutions Inc
TSX:HPS.A
|
CA |
|
KGHM Polska Miedz SA
WSE:KGH
|
PL |
|
N
|
Neuromeka Co Ltd
KOSDAQ:348340
|
KR |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
Braemar Hotels & Resorts Inc
F:42V
|
US |
Wall St Price Targets
VX1 Price Forecast
Based on 30 analysts
Based on 30 analysts
+129% Upside
from
€227.65
today
Vertex Pharmaceuticals Inc (VX1)’s 12-month stock price forecast through February 2021 has a consensus target of €521.08, implying 129% upside. The forecast is based on price targets from 30 Wall Street analysts.
VX1 Analyst Rating
No ratings yet
No ratings yet
Vertex Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
521.08
EUR
521.08
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 521.08 EUR with a low forecast of 311.36 EUR and a high forecast of 616.87 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
16%
16%
The compound annual growth rate for Net Income over the next 8 years is 16%.